The US Food and Drug Administration (FDA) has approved the first-ever CRISPR gene editing therapy, marking a significant breakthrough in medical science. This treatment, called "Zynteglo," can cure the rare blood disorder beta-thalassemia by altering patients' DNA. #US #FDA #DNA

Groundbreaking CRISPR Treatment Approved in the US

The FDA has approved the first-ever CRISPR gene editing therapy in the US, marking a significant milestone in medical science. This treatment holds promise for curing certain genetic diseases. #US